ADVASAN MEDICAL GROUP AS: årsregnskap 2022 vs 2021
Grew 5392% on revenue
approved 2023-06-05; registry 2023-06-20; journal 2023 503161
Summary
What changed
Comparing Årsregnskap 2022 with 2021 for ADVASAN MEDICAL GROUP AS. Revenue 105 NOK → 5 767 NOK (+5392.4%). Net result -23.3k NOK → -17.3k NOK. Equity 57.2k NOK → 39.9k NOK.
On the constructive side: revenue rose; operating result improved; net result improved. Pressures included: equity eroded; cash fell.
Mixed year — gains and pressures both show up.
At a glance
Scorecard
What improved
-
↑
Revenue rose
Operating income / revenue moved from 105 NOK to 5 767 NOK (+5392.4% YoY). Calculated
-
↑
Operating result improved
Operating result -23.6k NOK → -17.3k NOK (op. margin -22517.1% → -300.1%). Calculated
-
↑
Net result improved
Net result -23.3k NOK → -17.3k NOK (net margin -22158.1% → -299.9%). Calculated
What deteriorated
-
↓
Equity eroded
Book equity 57.2k NOK → 39.9k NOK (equity ratio 68.0% → 37.0%). Calculated
-
↓
Cash fell
Bank deposits 47.3k NOK → 31.2k NOK (-34.1% YoY). Calculated